VPS13A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.791600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.263000E-01
Normal-vs-Stage2
4.449800E-01
Normal-vs-Stage3
1.851580E-01
Normal-vs-Stage4
6.388800E-01
Stage1-vs-Stage2
1.924600E-01
Stage1-vs-Stage3
1.490010E-01
Stage1-vs-Stage4
6.471200E-01
Stage2-vs-Stage3
1.152800E-01
Stage2-vs-Stage4
4.237500E-02
Stage3-vs-Stage4
6.790400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.774200E-01
Normal-vs-AfricanAmerican
9.992200E-01
Normal-vs-Asian
5.352200E-01
Caucasian-vs-AfricanAmerican
4.333600E-01
Caucasian-vs-Asian
8.997400E-01
AfricanAmerican-vs-Asian
4.285200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.677200E-01
Normal-vs-Female
7.108000E-01
Male-vs-Female
3.262800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.632800E-01
Normal-vs-Age(41-60Yrs)
8.789000E-01
Normal-vs-Age(61-80Yrs)
4.529200E-01
Normal-vs-Age(81-100Yrs)
4.791200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.450000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.770400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.175200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.997700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.942560E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.871800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.869800E-01
Normal-vs-Daily Drinker
2.435400E-01
Normal-vs-Weekly Drinker
4.938200E-01
Normal-vs-Occasional Drinker
6.720000E-01
Normal-vs-Social Drinker
8.805200E-01
Non Drinker-vs-Daily Drinker
3.646000E-01
Non Drinker-vs-Weekly Drinker
8.099600E-01
Non Drinker-vs-Occasional Drinker
5.704000E-01
Non Drinker-vs-Social Drinker
1.633950E-01
Daily Drinker-vs-Weekly Drinker
6.772400E-01
Daily Drinker-vs-Occasional Drinker
2.309200E-01
Daily Drinker-vs-Social Drinker
7.031900E-02
Weekly Drinker-vs-Occasional Drinker
5.643600E-01
Weekly Drinker-vs-Social Drinker
1.868580E-01
Occasional Drinker-vs-Social Drinker
3.304200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.208390E-01
Normal-vs-Grade 2
1.235740E-02
Normal-vs-Grade 3
2.779700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.674600E-01
Grade 1-vs-Grade 3
3.249800E-01
Grade 1-vs-Grade 4
1.208390E-01
Grade 2-vs-Grade 3
2.672400E-01
Grade 2-vs-Grade 4
1.235740E-02
Grade 3-vs-Grade 4
2.779700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.259200E-01
Normal-vs-NonDiabetic
5.967600E-01
Diabetic-vs-NonDiabetic
5.794200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.843600E-01
Normal-vs-NoPancreatitis
5.019600E-01
Pancreatitis-vs-NoPancreatitis
7.505200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.650200E-01
Normal-vs-N1
4.164800E-01
N0-vs-N1
2.187200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.171600E-01
Normal-vs-TP53-NonMutant
9.609400E-01
TP53-Mutant-vs-TP53-NonMutant
2.184400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
